StockNow
Calendar
Log in
Other

AstraZeneca (AZN LN) recently made a roughly USD 10bln offer to acquire Rhythm Pharmaceuticals (RYTM) for USD 124/shr, reports WSJ citing sources

ORIGINAL · NewsquawkAstraZeneca (AZN LN) recently made a roughly USD 10bln offer to acquire Rhythm Pharmaceuticals (RYTM) for USD 124/shr, reports WSJ citing sources
StockNow breaking-news AI analysis

A breaking-news report attributes to WSJ sources a recent AstraZeneca offer to acquire Rhythm Pharmaceuticals for USD 124 per share, or roughly USD 10 billion; its status is unspecified.

2 stocks
AZNAstraZeneca PLC$189.25Current priceRYTMRhythm Pharmaceuticals, Inc. Common Stock$109.15Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

US Senate Democratic Leader Schumer says they will end the war, some Republicans have joined them; Americans don't know why a war was launched against Iran and it should end

Geopolitics

US President Trump has been asking advisers whether Defense Secretary Hegseth should stay in his job following Republicans’ heavy losses on Tuesday night, CBS News reports citing sources

U.S. Markets

Intel (INTC) CEO bought USD 9.71mln of stock at USD 64.73/shr amid the sell-off

INTC